Sinovac Biotech SVA
NASDAQ SVA
$6.47 +0.00 (+0.00%)
At close: Oct 28, 2026 · 4:00 PM EDT

Sinovac Biotech (SVA) Beginning Cash Balance (2017 - 2020)

Updated

Sinovac Biotech (SVA) posted Beginning Cash Balance of $70.2 million for Q4 2020, down 17.5% from $85.05 million a year earlier.

Analysis

Sinovac Biotech (SVA) Beginning Cash Balance (2017 - 2020) Analysis & Trends

Since Q4 2017, Sinovac Biotech has reported Beginning Cash Balance for 4 quarters.

  • Annual Beginning Cash Balance shows a three-year compound annual growth rate of 342.0% (FY2017 to FY2020).
  • In prior years, Sinovac Biotech's Beginning Cash Balance was $85.05 million in FY2019, $2.14 million in FY2018 (+163.2%) and $813,000 in FY2017.
  • The Q4 2020 figure stands as the lowest quarterly Beginning Cash Balance since Q4 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Sinovac Biotech 464.94 Mn -24.98 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 70.20 Mn
Dec 31, 2019 85.05 Mn
Dec 31, 2018 2.14 Mn
Dec 31, 2017 813,000.00
API Access

Sinovac Biotech Beginning Cash Balance API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=beginning-cash-balance&ticker=SVA&period=max&api_key=YOUR_API_KEY